关于更好的数据访问和数据整合在药监中的观点:焦点小组的信息
Florence van Hunsel1,2, Samantha Lane3,4, Dawn Cooper3,4
1Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, 's-Hertogenbosch, The Netherlands. f.vanhunsel@lareb.nl.
Drug safety
|January 14, 2026
概括
药物监管 (PV) 需要多模式数据分析和多种数据源的可访问性,以进行强大的药物安全监督. 挑战包括数据标准化,质量和访问,需要改进整合和严格.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 数据科学数据科学数据科学
背景情况:
- 药物监管 (PV) 对于监测药物安全性至关重要.
- 多样化的数据来源提供了独特的见解,但也带来了整合的挑战.
- 目前的光伏实践在数据标准化,质量和可访问性方面面临障碍.
研究的目的:
- 讨论药监监管当前的挑战和机遇.
- 强调在数据分析和可访问性方面需要采用多式联运方法.
- 探索改善全球药物安全监测的解决方案.
主要方法:
- 一个重点小组讨论与九名参与者,在光伏多部门的专业知识.
- 探索各种数据类型,包括临床试验和真实世界数据 (RWD).
- 识别药物监督方面的挑战和新兴工具.
主要成果:
- 确定了关键挑战:数据标准化,质量变化,技术障碍,道德问题 (社交媒体数据) 和数据访问差异.
- 像知识图这样的新兴工具显示了数据集成和信号检测的潜力.
- 突出了数据访问方面的差异,包括监管限制和有限的基础设施.
结论:
- 改善整合,访问和方法严格对于加强光伏实践至关重要.
- 提倡的解决方案包括促进数据透明度,安全的共享平台和协作联盟.
- 多式联络方式对于有效的全球药物安全监督至关重要.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Analysis of Population Pharmacokinetic Data
673
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
673
Bioavailability Study Design: Healthy Subjects Versus Patients
143
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
143
Measurement of Bioavailability: Pharmacodynamic Methods
230
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
230
Biopharmaceutics and Pharmacokinetics: Overview
3.3K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.3K
Drug Control Governance: Regulatory Bodies and Their Impact
489
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
489


